The Cutting Edge in Pharmaceutical Sciences -

50 Years of Progress Celebrating Les Benet’s 80th Birthday 


Following a decennial tradition, FIP is proud to sponsor this symposium celebrating the 50 Years of Progress in the Pharmaceutical Sciences in honor of the Chair of the first PSWC Congress, Professor Leslie Z. Benet. As at Les Benet’s 50th, 60thand 70.5 birthday symposia, leading scientists in our discipline will highlight the remarkable progress at the cutting edge of the science that we have observed over the past 50 years in our field. A celebratory banquet on Saturday evening will be held at the Scandic hotel with a separate registration (19:00, Scandic Hotel, Third Floor)


Saturday, 20 May 2017

08:30-17:45, Room K11



Margareta Hammarlund-Udenaes, Uppsala University, Sweden

Kathleen Giacomini, University of San Francisco California, USA

Douwe Breimer, Leiden University, The Netherlands


08:30-08:45        Symposium introduction

Douwe Breimer, Leiden University, Netherlands

08:45-09:15        Progress in drug administration technology and the future of medicine

Mitsuru Hashida, Kyoto University, Japan

09:15-09:45        What is happening inside: exploring gastrointestinal drug and formulation behavior

Patrick Augustijns, University of Leuven, Belgium

09:45-10:15        Model dependent and model independent approaches for the biopharmaceutic classification of drugs

Panos Macheras, University of Athens, Greece


10:15-10:45        COFFEE


10:45-10:50        Session Chairs Remarks

10:50-11:20        The role of PK in regulatory decision making – yesterday, today and the in future

Tomas Salmonson, Medical Products Agency, Sweden

11:20-11:50        New drug evaluation and approval in a model-based, Bayesian framework

Carl Peck, NDA Partners, USA

11:50-12:20        PK/PD as a source of innovative products delivering clinical value to patients

Suneel Gupta, IMPAX Laboratories, USA            


12:20-13:10        LUNCH


13:10-13:15        Session Chairs Remarks

13:15-13:45        The evolution of transporters in the SLC22 family

Kathleen Giacomini, University of California San Francisco, USA

13:45-14:15        Assessment of the effect of chronic kidney disease on CYP enzymes and transporters

Shiew-Mei Huang, Food and Drug Administration, USA

14:15-14:45        PK principles in target organs: Intracellular unbound drug concentrations and blood-brain barrier transport. Development of concepts and methodology

Margareta Hammarlund-Udenaes, Uppsala University, Sweden


14:45-15:15        COFFEE


15:15-15:20        Session Chair Remarks

15:20-15:50        Some reflections on pharmacokinetics

Malcolm Rowland, Manchester University, UK

15:50-16:20        Proposal of virtual clinical studies to examine the probability distribution of AUC at the target tissues; Application to irinotecan induced side effects

Yuichi Sugiyama, RIKEN Innovation Center, Japan

16:20-16:50        To Repurpose or not Repurpose, or “How much drug can I get to my target?” That is the question

Tudor Oprea, University of New Mexico, USA

16:50-17:20        Nonprofit drug development companies – A new paradigm

Victoria Hale, Medicines360, USA

17:20-17:30        Co-Chair Remarks

17:30-17:45        Les Benet Response


Symposium registration will include breakfast, lunch and coffee breaks. 

Registration for this symposium in addition to the full congress is possible during the online registration process 

Registration for this symposium only can be done HERE



Symposium only €350 excl VAT

Symposium plus banquet €400 excl VAT

Banquet only (for accompanying persons) €80 excl VAT


Student-postdoc (vs recent graduate):  

Symposium only €175 excl VAT

Symposium plus banquet €225 excl VAT